The role of histamine H4 receptor in the development of cancer-related fatigue
Project/Area Number |
21590279
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
General pharmacology
|
Research Institution | Osaka University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
HARUSAWA Shinya 大阪薬科大学, 薬学部, 教授 (90167601)
YAMAMOTO Kouichi 大阪大学, 大学院・医学系研究科, 助教 (40362694)
|
Project Period (FY) |
2009 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2009: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
Keywords | ヒスタミン / ヒスタミンH4受容体 / 腫瘍壊死因子(TNF)-α / がん治療関連倦怠感 / 抗悪性腫瘍薬 / マクロファージ / 腫瘍壊死因子(TNF) α / 細胞内情報伝達系MAPK / 活性酸素種(ROS) / 転写因子NF-κB / シスプラチン / がん関連倦怠感(Cancer-Related Fatigue : CRF) / がん関連倦怠感 / がん化学療法 / がん関連副作用 / 腫瘍壊死因子(TNF-α) / MAPK / 炎症性サイトカイン / がん関連疲労感 |
Research Abstract |
We hypothesized excessive tumor necrosis factor(TNF)-αproduction via histamine H4 receptor(H4R) is concerned in cancer-therapy related fatigue. We found that cisplatin increased TNF-αmRNA expressions in macrophages. Histamine H4R agonists inhibited the cisplatin-induced TNF-αmRNA expression, but treatment with H4R antagonist aggravated the effect. These results suggest that activation of H4R attenuates cisplatin-induced TNF-αmRNA expression and that H4R agonists are expected to be useful for treatment of cancer-therapy related fatigue.
|
Report
(4 results)
Research Products
(9 results)